Trabectedin not superior to chemotherapy in recurrent epithelial ovarian cancerĀ Presented ByDr Domenica Lorusso, San Raffaele Scientific Institute, Italy TrialPhase 3, MIT023 ConferenceASCO 2022 TypePeer-reviewed article 5 August 2022 15:25
Treatment of recurrent ovarian cancer ConferenceESMO 2020 TypePeer-reviewed article 25 November 2020 14:35